Cooper Companies vs STAAR Surgical
COO and STAA side by side, both in measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How COO and STAA compare
Cooper Companies is the larger company, worth 9.0 times as much as STAAR Surgical ($11.9B against $1.3B).
STAAR Surgical grew revenue faster over the last twelve months (42.4% versus 4.7% for Cooper Companies).
Cooper Companies keeps more of each dollar of sales as profit, with a net margin of 13.5% compared with 0.16% at STAAR Surgical.
Cooper Companies scores higher on the StockData Score (16 against 8 for STAAR Surgical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | COO | STAA |
|---|---|---|
| Size and price | ||
| Market cap | $11.9B | $1.3B |
| Share price | $62.65 | $26.39 |
| Change, 1 year | −13.6% | 2.1% |
| Change, 5 years | −38.1% | −76.0% |
| Beta (5Y) | 0.94 | 1.48 |
| Employees | 500 | 957 |
| StockData Score | ||
| Total score | 16 (better) | 8 |
| Valuation score | 6 (better) | 0 |
| Growth score | 1 | 1 |
| Performance score | 3 (better) | 1 |
| Health score | 6 | 6 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 21.4× | – |
| P/S | 2.8× (better) | 4.0× |
| P/B | 1.4× (better) | 3.5× |
| EV/EBITDA | 15.4× (better) | 1593× |
| P/FCF | 17.6× (better) | 74.1× |
| FCF yield | 5.7% (better) | 1.3% |
| Fair value | $98.73 | – |
| Margin of safety | 36.5% | – |
| Growth | ||
| Revenue growth (TTM) | 4.7% | 42.4% (better) |
| Revenue growth, 5Y average | 11.0% (better) | 7.9% |
| Net income growth (TTM) | 39.8% | – |
| EPS growth (TTM) | 43.6% | – |
| EPS growth, 5Y average | 9.2% | – |
| Profitability | ||
| Gross margin | 65.9% | 73.6% (better) |
| Operating margin | 12.8% (better) | 0.21% |
| Net margin | 13.5% (better) | 0.16% |
| FCF margin | 16.0% (better) | 5.4% |
| Return on equity | 6.8% (better) | 0.15% |
| Return on invested capital | 5.1% (better) | 0.21% |
| Financial health | ||
| Debt / equity | 0.31 (better) | 0.00 |
| Net debt / EBITDA | 2.57 | – |
| Interest coverage | 6.1× | – |
| Current ratio | 1.22 | 4.68 (better) |
| Altman Z-score | 3.06 | 8.28 (better) |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Buyback yield | 5.4% | – |
| Shareholder yield | 5.4% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 110% | 110% |
| Held by insiders | 0.65% | – |
| Insider net buying, 12 months | $3.2M | $21.7M (better) |
| Superinvestors holding | 2 | – |
| Short interest, % of float | 5.4% | – |
Go deeper
- COO stock overview
- COO income statement
- COO valuation and score
- STAA stock overview
- STAA income statement
- STAA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.